Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jiawei Qilang Decoction is a Traditional Chinese Medicine (TCM) herbal formula developed by the Shanghai Municipal Hospital of Traditional Chinese Medicine for the treatment of drug-dependent constipation. This condition is characterized by a chronic reliance on stimulant laxatives, which often leads to impaired colonic motility and decreased rectal sensitivity. The decoction is a modified version of the 'Qilang' (likely referring to the herbs *Astragalus* and *Areca nut*) prescription, designed to restore normal bowel function, improve stool consistency, and facilitate the withdrawal from external laxatives. It has been evaluated in randomized, double-blind, placebo-controlled clinical trials in China to assess its efficacy in increasing the frequency of spontaneous bowel movements and improving the quality of life for patients suffering from chronic, drug-reliant constipation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on jiawei qilang decoction.